Figure 2From: Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes Incremental cost-effectiveness scatter plot: CGM and SMBG vs. SMBG only. Incremental cost-effectiveness scatter plot of continuous glucose monitoring (CGM) and self-monitoring of blood glucose (SMBG) vs. SMBG only. The diagonal dashed line represents US$50,000 per quality-adjusted life year. Each point represents one Monte Carlo simulation.Back to article page